Dr. Robert Lanza, vice president of Research and Scientific Development for Worcester-based Advanced Cell Technology (ACT), will be honored at the 11th annual Mass High Tech All-Stars Awards Networking Reception on Wednesday at the category biotechnology. Link Lanza is a key person in American human embryonic stem cell technology. Some public rearguard actions of the… Continue reading New England All-Stars Award goes to Advanced Cell’s Lanza
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework
From PharmaLive: Aldagen, Inc. and Innovative Micro Technology (IMT) today announced that they have formed an alliance to co-develop and commercialize a version of IMT’s Rare Cell Purification System, customized specifically for clinical cell therapies. This system, called the ALDESORTER(TM), will be used with Aldagen’s ALDESORT(R) product and is designed to isolate unique stem cell… Continue reading Yet another industrial stem cell alliance: Aldagen meets IMT
As I mentioned before, continuous regeneration treatment of the whole human body called Pimm could be interpreted as inside plastic surgery for functional reasons. And now here comes one nice example of the present biotech trend:
From Investor’s Business Daily: Big pharmaceutical firms and major biotechs are holding back as well, William Caldwell CEO of Advanced Cell Technology says. “While all of them have stem cell development labs someplace in the bowels of their organizations, they are not putting capital into the sector.” These companies are nervous about the political and… Continue reading U.S. stem cell companies: a new roundup
$16-million round of financing goes for Gamida Cell to bring StemEx, a treatment for leukemia and lymphoma to the market. From Red Herring: The funds will be used to expand the Israeli stem cell startup’s pipeline and bring products to market. …The company reported extremely favorable clinical results from phase I and II studies of… Continue reading $16Million Israeli fund for anti leukemia treatment StemEx
Is Amatokin the first product to harness the potential of your own stem cells to reduce serious wrinkles? From Businesswire: This “super-secret” wrinkle cream, called Amatokin, is not really a cream at all, but a “highly efficient ‘barrier-neutral’ emulsion” containing a unique polypeptide compound (known in official circles as polypeptide #153). This meta-peptide was developed… Continue reading Rumors on Amatokin: a skin stem cell wrinkle cream?